National Institute of Immunohaematology (ICMR), Mumbai, India.
Clin Genet. 2023 Mar;103(3):268-276. doi: 10.1111/cge.14256. Epub 2022 Nov 4.
MicroRNAs are the major class of small non-coding RNAs, evolutionary conserved post-transcriptional regulators of gene expression. Since their discovery in 1993, they have been implicated as master regulators in numerous cellular processes. MicroRNA (miRNA)s regulate gene expression by attenuation and/or mRNA degradation and are commonly associated with cell development, differentiation, and homeostasis. Extensive research in past two decades has provided new insights into the potential implications of miRNA in the onset, progression, and therapeutic nature of miRNAs in disease manifestation. Owing to the novel discoveries, "miRNAs" would probably pave a new direction in therapeutic research. However, "micro" in length miRNAs have attracted considerable attention in numerous other fields. Understanding the functionality of miRNAs, in this review article, we discussed the mechanistic role of miRNAs in human diseases and have outlined most of the recent published work in clinical therapeutics. We have constructed different network models for miRNA and its targets which made us understand their interrelationship and association with diseases. Future research would surely overcome challenges and would introduce new strategies for the utility of miRNAs in a broader setting.
MicroRNAs 是小非编码 RNA 的主要类别,是基因表达的进化保守的转录后调控因子。自 1993 年发现以来,它们已被认为是许多细胞过程的主要调控因子。MicroRNA(miRNA)通过衰减和/或 mRNA 降解来调节基因表达,通常与细胞发育、分化和内稳态有关。在过去的二十年中,广泛的研究为 miRNA 在疾病表现中的发病机制、进展和治疗性质提供了新的见解。由于新的发现,“miRNA”可能会为治疗研究开辟新的方向。然而,由于 miRNA 的长度较短,它们在许多其他领域引起了相当大的关注。在这篇综述文章中,我们讨论了 miRNA 在人类疾病中的作用机制,并概述了最近在临床治疗方面发表的大部分工作。我们构建了 miRNA 及其靶标的不同网络模型,这使我们了解了它们与疾病的相互关系和关联。未来的研究肯定会克服挑战,并为 miRNA 在更广泛的环境中的应用引入新的策略。